Phosphodiesterase-4 inhibitors for the treatment of inflammatory diseases

H Li, J Zuo, W Tang - Frontiers in pharmacology, 2018 - frontiersin.org
Phosphodiesterase-4 (PDE4), mainly present in immune cells, epithelial cells, and brain
cells, manifests as an intracellular non-receptor enzyme that modulates inflammation and …

PDE4 inhibitors: potential protective effects in inflammation and vascular diseases

T Fan, W Wang, Y Wang, M Zeng, Y Liu… - Frontiers in …, 2024 - frontiersin.org
Phosphodiesterase 4 (PDE4) inhibitors are effective therapeutic agents for various
inflammatory diseases. Roflumilast, apremilast, and crisaborole have been developed and …

Advances in the development of phosphodiesterase-4 inhibitors

G Li, D He, X Cai, W Guan, Y Zhang, JQ Wu… - European Journal of …, 2023 - Elsevier
Abstract Phosphodiesterase 4 (PDE4) hydrolyzes cyclic adenosine monophosphate (cAMP)
and plays a vital roles in many biological processes. PDE4 inhibitors have been widely …

[HTML][HTML] PDE4D: a multipurpose pharmacological target

M Lusardi, F Rapetti, A Spallarossa… - International Journal of …, 2024 - mdpi.com
Phosphodiesterase 4 (PDE4) enzymes catalyze cyclic adenosine monophosphate (cAMP)
hydrolysis and are involved in a variety of physiological processes, including brain function …

Targeting phosphodiesterase 4 as a potential therapeutic strategy for enhancing neuroplasticity following ischemic stroke

H Wang, U Gaur, J **ao, B Xu, J Xu… - International journal of …, 2018 - pmc.ncbi.nlm.nih.gov
Sensorimotor recovery following ischemic stroke is highly related with structural modification
and functional reorganization of residual brain tissues. Manipulations, such as treatment …

[PDF][PDF] Reduction of lung inflammation, oxidative stress and apoptosis by the PDE4 inhibitor roflumilast in experimental model of acute lung injury.

P Kosutova, P Mikolka, M Kolomaznik… - Physiological …, 2018 - biomed.cas.cz
Damage of alveolar-capillary barrier, inflammation, oxidative injury, and lung cell apoptosis
represent the key features of acute lung injury (ALI). This study evaluated if selective …

Synthetic Approaches and Clinical Application of Representative Small-Molecule Inhibitors of Phosphodiesterase

Q Chen, Y **a, HN Liu, Y Chi, X Li, LS Shan… - European Journal of …, 2024 - Elsevier
Phosphodiesterases (PDEs) constitute a family of enzymes that play a pivotal role in the
regulation of intracellular levels of cyclic nucleotides, including cyclic adenosine …

[HTML][HTML] Comparative transcriptome profiling and functional analysis in the blood of tiger puffer (Takifugu rubripes) in response to acute hypoxia

Y Lu, Y Li, M Bao, F Shang, R Wei, F Liu, Y Liu… - Aquaculture …, 2023 - Elsevier
Dissolved oxygen (DO) is an essential ecological factor encountered by fish and other
aquatic animals, and hypoxia can adversely affect the physiology, biochemistry and …

[PDF][PDF] An efficient synthesis and antimicrobial evaluation of 5-alkenyl-and 5-styryl-1, 2, 4-oxadiazoles

M Tarasenko, V Sidneva, A Belova… - Arkivoc, 2018 - pdfs.semanticscholar.org
The cyclodehydration of O-acylamidoximes at room temperature in the superbase system
KOH/DMSO represents a simple and efficient way to 5-alkenyl-and 5-styryl-1, 2, 4 …

Molecularly targeted therapies for asthma: Current development, challenges and potential clinical translation

I Sulaiman, JCW Lim, HL Soo, J Stanslas - Pulmonary pharmacology & …, 2016 - Elsevier
Extensive research into the therapeutics of asthma has yielded numerous effective
interventions over the past few decades. However, adverse effects and ineffectiveness of …